Key points from article :
Synchron is part of an emerging crop of companies testing technology in the brain-computer interface industry.
The system is implanted through the blood vessels and allows patients to operate technology using only their minds.
“It helps them engage in ways that we take for granted,” Synchron CEO Tom Oxley said.
The Synchron Switch is implanted through the blood vessels to allow people with no or very limited physical mobility to operate technology using their minds.
Synchron’s stent, called the Stentrode, is fitted with tiny sensors and is delivered to the large vein that sits next to the motor cortex.
“It’s a bit more scalable, compared to open-brain surgery, which only neurosurgeons can perform,” Peter Yoo, senior director told.
Patients with severe paralysis or degenerative diseases can regain their ability to communicate through typing, texting or even accessing social media.
The results were published in JAMA Neurology and carried out at Synchron lab.
